Clinical Trial Update: Pappalysin 2 (PAPP-A2) Enzyme Replacement [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 clinical trial evaluating PAPP-A2 enzyme replacement therapy for idiopathic short stature.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• PAPP-A2 enzyme replacement (pappalysin-2)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Short Stature, Idiopathic | Phase 1 | Status: COMPLETED